EB

Comprehensive notes on the Autonomic Nervous System (SNS vs PNS)

Overview and Core Concepts

  • Regulate the organs, glands, and glands; pursue homeostasis and allostasis (maintaining stability through change).

  • Allostasis: adjusting physiological set-points to cope with changing conditions; essential for adaptive responses.

  • Two main divisions of the nervous system:

    • Central nervous system (CNS): brain and spinal cord.

    • Peripheral nervous system (PNS): all nervous tissue outside the CNS (sensory and motor neurons).

  • Basic functions of the nervous system:

    • Monitor internal and external environmental changes.

    • Process and integrate perceived changes.

    • React to changes by producing an action or response.

    • Maintain homeostasis through coordinated responses.

Functional Divisions of the PNS

  • Sensory (afferent) neurons: detect internal and external changes.

  • Motor division:

    • Somatic nervous system (SNS): voluntary control of skeletal muscle.

    • Autonomic nervous system (ANS): involuntary control of cardiac muscle, smooth muscle, and glands.

  • Quick contrast:

    • Voluntary actions (reading a book, walking, typing) involve somatic motor control.

    • Involuntary actions (heart beating, gut activity) involve ANS.

Autonomic Nervous System (ANS)

  • ANS uses a two-neuron chain to connect the CNS to target organs:

    • Preganglionic neuron: leaves the CNS, synapses in a ganglion outside the CNS.

    • Postganglionic neuron: located beyond the ganglion, synapses on the target organ.

    • The path CNS → ganglion → target organ constitutes a ganglionic synapse and a second synapse to the organ.

  • ANS signals can be teased apart into two major divisions that often produce opposite effects, but there are exceptions.

    • Sympathetic (thoracolumbar) division: thoracic and lumbar spinal cord origins; preganglionic neurons originate from T1–L2.

    • Parasympathetic (craniosacral) division: brainstem (medulla) and sacral spinal cord origins; preganglionic neurons originate from cranial nerves III, VII, IX, X and sacral spinal nerves S2–S4.

  • Primary neurotransmitters and receptors:

    • Acetylcholine (ACh): used by preganglionic neurons in both sympathetic and parasympathetic divisions; acts on nicotinic receptors at ganglia.

    • Norepinephrine (NE): primary transmitter of the sympathetic division; acts on adrenergic receptors on target organs.

    • Epinephrine (adrenaline): released from adrenal medulla; acts systemically on adrenergic receptors; not a direct transmitter at all autonomic ganglia.

    • Receptors:

    • Nicotinic receptors: located at the ganglionic synapse (both sympathetic and parasympathetic divisions) and at the neuromuscular junction (somatic NS).

    • Muscarinic receptors: located on organs innervated by postganglionic parasympathetic neurons.

  • Drugs and clinical relevance:

    • Drugs can be agonists (activate receptors) or antagonists/blockers (block receptors).

    • Most autonomic-acting drugs act at the postganglionic (second) neuron's synapse onto the organ.

    • Terms to know: cholinergic (nerve fibers that release ACh) and anticholinergic (block ACh actions).

  • Summary of cholinergic vs adrenergic transmission:

    • ACh is the primary transmitter for parasympathetic signaling; acts on muscarinic receptors on target organs and nicotinic receptors at ganglia.

    • NE is the primary transmitter for sympathetic signaling; acts on alpha and beta adrenergic receptors on target organs.

    • In addition, preganglionic neurons release ACh to activate nicotinic receptors in both divisions; postganglionic sympathetic neurons release NE to adrenergic receptors on organs; parasympathetic postganglionic neurons release ACh to muscarinic receptors.

  • Practical implication: understanding these pathways helps predict drug actions and side effects (e.g., a drug that blocks muscarinic receptors will oppose parasympathetic activity).

Receptors in Focus: Nicotinic vs Muscarinic

  • Nicotinic receptors:

    • Location: ganglionic synapses in both sympathetic and parasympathetic divisions; neuromuscular junction in skeletal muscle.

    • Activation effects: broad physiologic effects due to widespread distribution (tachycardia, hypertension, increased GI tone, etc.).

    • Drugs targeting nicotinic receptors can cause broad autonomic and somatic effects.

  • Muscarinic receptors:

    • Location: on target organs innervated by postganglionic parasympathetic neurons.

    • Activation produces classic parasympathetic (rest-and-digest) responses: increased GI secretions and motility, bradycardia, bronchoconstriction, pupillary constriction, etc.

    • Drugs acting on muscarinic receptors include cholinergic agonists (activate) and anticholinergics (block).

  • Key term corrections from the lecture notes:

    • Mydriasis = pupil dilation.

    • Miosis = pupil constriction.

    • Tachycardia: rapid heart rate; bradycardia: slow heart rate.

    • Note: some slides in the transcript used spellings like “myosis” for miosis; correct term is miosis.

Autonomic Effects by Division

  • Sympathetic nervous system (SNS): fight-or-flight

    • Origin: thoracolumbar (T1–L2).

    • Primary effects on organs:

    • Heart: ↑ heart rate and contractility.

    • Lungs: bronchodilation to allow more air in.

    • Eyes: pupil dilation (mydriasis).

    • GI tract: ↓ secretions and ↓ motility.

    • Liver/pancreas: glucose release for energy.

    • Blood vessels: vasoconstriction in many areas (↑ BP); some vessels may dilate in skeletal muscle via β2 receptors.

    • Sweat glands: stimulated by sympathetic nerves (often via cholinergic receptors).

    • Neurotransmitter actions: NE (and epinephrine from adrenal medulla) acting on α and β adrenergic receptors; some postganglionic sympathetic fibers release ACh to sweat glands (muscarinic receptors).

  • Parasympathetic nervous system (PNS): rest-and-digest

    • Origin: craniosacral (medulla and sacral segments).

    • Primary effects on organs:

    • Heart: ↓ heart rate and ↓ contractility (primarily via muscarinic receptors).

    • Lungs: bronchoconstriction (slower breathing when at rest).

    • Eyes: pupil constriction (miosis).

    • GI tract: ↑ secretions and ↑ motility (digestion).

    • Urinary and reproductive systems: promotion of urination and various reproductive functions.

    • Neurotransmitter actions: ACh acting on muscarinic receptors on target organs; nicotinic receptors at ganglia.

Special Topics and Practical Insights

  • Exceptions to opposite effects:

    • Some tissues are primarily under sympathetic control (e.g., arterioles and sweat glands), with limited parasympathetic counterbalance.

    • Arteriolar constriction is controlled predominantly by the sympathetic branch.

  • Clinical relevance of dual innervation:

    • Most organs receive input from both divisions, allowing fine-tuned regulation (dominant tone may vary by tissue and situation).

    • In disease or pharmacology, shifting the balance can predict symptoms and drug effects.

  • The role of the adrenal medulla:

    • Epinephrine is released into the bloodstream, acting on adrenergic receptors throughout the body; it is not a direct postganglionic neurotransmitter at a specific organ but amplifies SNS effects systemically.

  • Receptor distribution and drug implications:

    • Targeting nicotinic receptors can cause broad autonomic and somatic effects due to their presence in ganglia and NMJ.

    • Targeting muscarinic receptors yields parasympathetic-specific effects on organs, useful for cholinergic agonists and anticholinergics.

  • Practical pharmacology points:

    • Drugs acting on the ANS often aim at the final effector organ (postganglionic junction).

    • Pharmacologic effects depend on receptor type and tissue distribution (α vs β adrenergic, nicotinic vs muscarinic).

  • Key terms to recognize:

    • Tachycardia: rapid heart rate.

    • Bradycardia: slow heart rate.

    • Mydriasis: pupil dilation.

    • Miosis: pupil constriction.

    • Cholinergic agonist: drug that mimics ACh.

    • Anticholinergic (muscarinic blocker): drug that blocks muscarinic receptors.

    • Adrenergic receptor subtypes: alpha (α) and beta (β) receptors on organs.

Spinal and Cranial Anatomy References

  • Vertebral and spinal counts mentioned in the lecture:

    • Cervical vertebrae: 7

    • Thoracic vertebrae: 12

    • Lumbar vertebrae: 5

    • Coccyx (tailbone): part of the sacral/pelvic region.

  • Primary CNS connection points:

    • Sympathetic: thoracic and lumbar nerves (thoracolumbar).

    • Parasympathetic: medulla (cranial nerves) and sacral sacral nerves (craniosacral).

Critical Thinking and Example Scenarios

  • Case-based reasoning (from the transcript): ER patient after motor vehicle accident with rapid heart rate, dilated pupils, and decreased digestive activity.

    • Most likely dominant division: Sympathetic nervous system (fight-or-flight).

    • Expected: tachycardia, mydriasis, reduced GI secretions and motility, etc.

  • Exam-style practice prompts:

    • Compare parasympathetic and sympathetic effects on heart rate, pupil size, airway tone, and GI activity.

    • Identify which receptor types mediate specific organ responses (muscarinic vs nicotinic vs adrenergic).

    • Predict drug effects if a muscarinic receptor blocker is used.

Summary of Key Takeaways

  • The ANS uses a two-neuron chain (preganglionic → ganglion → postganglionic → organ) to regulate cardiac muscle, smooth muscle, and glands.

  • Sympathetic (thoracolumbar) promotes fight-or-flight responses; parasympathetic (craniosacral) promotes rest-and-digest functions.

  • ACh is the main neurotransmitter for parasympathetic and somatic NMJ; NE is the main transmitter for sympathetic pathways; epinephrine acts systemically from the adrenal medulla.

  • Receptors:

    • Nicotinic: ganglia and NMJ; broadly excitatory when stimulated.

    • Muscarinic: target organs of the parasympathetic system; produce rest-and-digest effects.

  • Drugs target the ANS at the postganglionic junction and can be either agonists or antagonists, with effects on heart rate, glandular secretions, GI motility, pupil size, airway caliber, and more.

  • Important numbers to remember from the lecture:

    • Cervical vertebrae: 7

    • Thoracic vertebrae: 12

    • Lumbar vertebrae: 5

    • Tachycardia and bradycardia thresholds in the lecture: tachycardia is described as > 400 in one slide (clinically this is typically > 100 bpm), bradycardia as < 60 bpm.

  • Terms to know: mydriasis, miosis, tachycardia, bradycardia, nicotinic receptors, muscarinic receptors, cholinergic, anticholinergic, adrenergic (α and β) receptors.

Quick Reference Glossary (narrative form)

  • Allostasis: adaptive stability through change to meet environmental demands.

  • Thoracolumbar: relating to the sympathetic outflow from thoracic and lumbar regions of the spinal cord.

  • Craniosacral: relating to parasympathetic outflow from brainstem and sacral spinal cord.

  • Mydriasis: pupil dilation.

  • Miosis: pupil constriction.

  • Tachycardia: fast heart rate; Br
    adycardia: slow heart rate.

  • Cholinergic: nerve fibers releasing acetylcholine; cholinergic agonists mimic ACh, anticholinergics block ACh.

  • Adrenergic: receptors responsive to adrenaline/epinephrine and norepinephrine.

  • Nicotinic vs Muscarinic receptors: different locations and roles in autonomic signaling.

Note: Some numerical values and spellings in the source transcript contain inconsistencies (e.g., reported tachycardia threshold of >400 bpm). In clinical practice, tachycardia is generally defined as a heart rate > 100 bpm and bradycardia as < 60 bpm. This notes compilation preserves the transcript content while marking such discrepancies for your awareness during study.